This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

5 Stocks Under $10 Set to Soar

Bioline Rx

One under-$10 stock that's trending very close to trigger a big breakout is Bioline Rx (BLRX), a clinical-stage biopharmaceutical development company engaged in identifying, in-licensing and developing therapeutic compounds in areas of central nervous system, oncology, cardiovascular and infectious diseases. This stock has been hammered by the bears so far in 2013, with shares off by 28%.

If you take a look at the chart for Bioline Rx, you'll notice that this stock recently gapped down sharply from over $3.75 to $1.60 a share with heavy downside volume. Following that move, shares of BLRX have started to reverse its bearish price trend and rebound higher, with the stock hitting a recent high of $2.16 a share. That move is quickly pushing shares of BLRX within range of triggering a major breakout trade.

>>4 Health Care Stocks Under $10 to Watch

Traders should now look for long-biased trades in BLRX if it manages to break out above some near-term overhead resistance levels at $2 to $2.16 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 284,000 shares. If that breakout triggers soon, then BLRX will set up to re-fill some of its previous gap down zone from March that started above $3.75 a share.

Traders can look to buy BLRX off weakness to anticipate that breakout and simply use a stop that sits just below $1.75 a share. One can also buy off strength once BLRX takes out those breakout levels with volume and then simply use a stop a few percentage points below your entry point.

2 of 6

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,122.01 +15.31 0.09%
S&P 500 2,000.12 +0.10 0.00%
NASDAQ 4,569.6210 -1.0160 -0.02%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs